169 related articles for article (PubMed ID: 30604723)
1. Primary cutaneous B-cell lymphoma: A single-center 5-year experience.
Jacob LA; Asati V; Lakshmaiah KC; Govind BK; Lokanatha D; Babu SM; Lokesh KN; Rudresh AH; Rajeev LK; Mulchandani NJ; Anand A; Koppaka D; Mysore SN
Indian J Cancer; 2018; 55(2):134-137. PubMed ID: 30604723
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous B-cell lymphoma in Japanese patients.
Liu Q; Ohshima K; Kikuchi M
Pathol Int; 2000 Dec; 50(12):960-6. PubMed ID: 11123762
[TBL] [Abstract][Full Text] [Related]
3. Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University.
Haverkos B; Tyler K; Gru AA; Winardi FK; Frederickson J; Hastings J; Elkins C; Zhang X; Xu-Welliver M; Wong HK; Porcu P
Oncologist; 2015 Oct; 20(10):1161-6. PubMed ID: 26306900
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea.
Kim MJ; Hong ME; Maeng CH; Jung HA; Hong JY; Choi MK; Kim SJ; Ko YH; Kim WS
Int J Hematol; 2015 Mar; 101(3):273-8. PubMed ID: 25552248
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management.
Sokol L; Naghashpour M; Glass LF
Cancer Control; 2012 Jul; 19(3):236-44. PubMed ID: 22710899
[TBL] [Abstract][Full Text] [Related]
6. Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas--an applicational observation.
Gellrich S; Muche JM; Wilks A; Jasch KC; Voit C; Fischer T; Audring H; Sterry W
Br J Dermatol; 2005 Jul; 153(1):167-73. PubMed ID: 16029344
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous B-cell lymphoma in Nottinghamshire U.K.: prognosis of subtypes defined in the WHO-EORTC classification.
Bessell EM; Humber CE; O'Connor S; English JS; Perkins W; Dickinson PD; Patel AN
Br J Dermatol; 2012 Nov; 167(5):1118-23. PubMed ID: 22759204
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B-cell lymphoma.
Eich HT; Eich D; Micke O; Süttzer H; Casper C; Krieg T; Müller RP
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):899-906. PubMed ID: 12605967
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions.
Suárez AL; Querfeld C; Horwitz S; Pulitzer M; Moskowitz A; Myskowski PL
J Am Acad Dermatol; 2013 Sep; 69(3):343.e1-11; quiz 355-6. PubMed ID: 23957985
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas.
Zinzani PL; Quaglino P; Pimpinelli N; Berti E; Baliva G; Rupoli S; Martelli M; Alaibac M; Borroni G; Chimenti S; Alterini R; Alinari L; Fierro MT; Cappello N; Pileri A; Soligo D; Paulli M; Pileri S; Santucci M; Bernengo MG;
J Clin Oncol; 2006 Mar; 24(9):1376-82. PubMed ID: 16492713
[TBL] [Abstract][Full Text] [Related]
11. Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas.
Fabbri A; Cencini E; Alterini R; Rubegni P; Rigacci L; Delfino C; Puccini B; Fimiani M; Bosi A; Bocchia M; Pimpinelli N;
Eur J Haematol; 2014 Aug; 93(2):129-36. PubMed ID: 24635751
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.
Paulli M; Lucioni M; Maffi A; Croci GA; Nicola M; Berti E
G Ital Dermatol Venereol; 2012 Dec; 147(6):589-602. PubMed ID: 23149705
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous B-cell lymphomas. Current concepts. I.
Santucci M; Pimpinelli N
Haematologica; 2004 Nov; 89(11):1360-71. PubMed ID: 15531459
[TBL] [Abstract][Full Text] [Related]
14. IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma.
Koens L; Vermeer MH; Willemze R; Jansen PM
Am J Surg Pathol; 2010 Jul; 34(7):1043-8. PubMed ID: 20551823
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions.
Kempf W; Kazakov DV; Mitteldorf C
Am J Dermatopathol; 2014 Mar; 36(3):197-208; quiz 209-10. PubMed ID: 24658377
[TBL] [Abstract][Full Text] [Related]
16. Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience.
Hamilton SN; Wai ES; Tan K; Alexander C; Gascoyne RD; Connors JM
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):719-25. PubMed ID: 24001373
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification.
Suárez AL; Pulitzer M; Horwitz S; Moskowitz A; Querfeld C; Myskowski PL
J Am Acad Dermatol; 2013 Sep; 69(3):329.e1-13; quiz 341-2. PubMed ID: 23957984
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous spindle cell B cell lymphoma: A report of three cases and review of the literature.
Magro CM; Momtahen S
Ann Diagn Pathol; 2017 Apr; 27():18-23. PubMed ID: 28325356
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous B-cell lymphoma: review and current concepts.
Pandolfino TL; Siegel RS; Kuzel TM; Rosen ST; Guitart J
J Clin Oncol; 2000 May; 18(10):2152-68. PubMed ID: 10811681
[TBL] [Abstract][Full Text] [Related]
20. Primary extranodal non-Hodgkin's lymphoma of oral cavity--a single centre retrospective study.
Sirsath NT; Lakshmaiah KC; Das U; Lokanatha D; Chennagiri SP; Ramarao C
J Cancer Res Ther; 2014; 10(4):945-50. PubMed ID: 25579534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
